Stock comparison
METTLER TOLEDO INTERNATIONAL INC/ is 22.4x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($27.68 B vs $1.23 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MTD is larger
METTLER TOLEDO INTERNATIONAL INC/ is 22.4x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($27.68 B vs $1.23 B).
Market value leader
MTD
METTLER TOLEDO INTERNATIONAL INC/ is 22.4x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($27.68 B vs $1.23 B).
Revenue leader
MTD
EYPT: $31.37M vs MTD: $4.03B.
Profit leader
MTD
EYPT: -$231.96M vs MTD: $869.19M.
Margin leader
MTD
EYPT: -739.4% vs MTD: 21.6% net margin.
| Metric | EYPT | MTD |
|---|---|---|
| Market cap | $1.23 B | $27.68 B |
| US-listed rank | #2501 | #504 |
| Revenue (latest FY) | $31.37M | $4.03B |
| Net income (latest FY) | -$231.96M | $869.19M |
| Net margin | -739.4% | 21.6% |
| P/E (trailing FY) | - | 31.8x |
| SEC filings | 1,308 | 1,692 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
METTLER TOLEDO INTERNATIONAL INC/ is 22.4x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($27.68 B vs $1.23 B).
In their latest fiscal years, EyePoint Pharmaceuticals, Inc. reported $31.37M in revenue while METTLER TOLEDO INTERNATIONAL INC/ reported $4.03B.
Full pages: EyePoint Pharmaceuticals, Inc. and METTLER TOLEDO INTERNATIONAL INC/, or browse the full rankings.